Top Markets
#1 Siren Siren +34.00%
#2 OriginTrail OriginTrail +29.98%
#3 Waves Waves +14.16%
#4 BasedHype BasedHype +7.63%
#5 Pons Pons +7.39%
#6 MarsCoin MarsCoin +7.06%
#7 Arcium Arcium +6.31%
#8 Cysic Cysic +6.31%
#9 TROLL TROLL +6.06%
#10 PulseChain PulseChain +5.89%
Coin of the day
Siren Siren
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Intech Biopharm Corporation Intech Biopharm Corporation

Intech Biopharm Corporation

6461
Rangering i aksjer #22451
Intech Biopharm Corporation is a pharmaceutical company dedicated to the global... Intech Biopharm Corporation is a pharmaceutical company dedicated to the global development and production of generic medications for respiratory conditions. Their portfolio includes innovative drug delivery systems, such as iLEF (inhaled low ethanol formulation), a proprietary metered dose inhaler platform specifically engineered for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Additionally, they offer a dry powder inhaler (DPI) technology, which utilizes blisters and capsules for precise dosage. These therapeutic solutions are marketed under various brand names, including SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011. Established in Taipei, Taiwan, in 2010, the company maintains its headquarters in the city.
Aksjekurs
$0.49606484
Sist synkronisert: 2026-08-21
Markedsverdi
$88.47M
Endring (1 dag)
-1.58%
Endring (1 år)
-22.51%
Land
TW
Handel Intech Biopharm Corporation (6461)

Kategori

Healthcare
Inntekter for Intech Biopharm Corporation (6461)
Inntekter i 2026 TTM: 0
Ifølge Intech Biopharm Corporation sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Intech Biopharm Corporation fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH